Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 23, 2008. The document serves as a notification of a change in major shareholding interests rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder ownership data.
Material Changes
The material change reported is a notification from Legal & General Group plc regarding an acquisition or disposal of voting rights in GlaxoSmithKline plc Ordinary shares (25 pence each). The transaction date was September 22, 2008, and the issuer was notified on September 23, 2008.
- Entity: Legal & General Group plc (Group) and Legal & General Investment Management Limited (LGIM).
- Threshold Status: The notification indicates the interest remains below the 5% threshold.
- Shareholding Details:
- Legal & General Group Plc (Direct): 243,167,549 shares (4.65% voting rights).
- Legal & General Investment Management (Holdings) Limited (Direct): 199,362,809 shares (3.82% voting rights).
- Total voting rights base used for calculation: 5,218,693,637.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, risk factors, contingencies, or unusual items. The document is a regulatory disclosure of ownership structure changes.
Investor Verification Checklist
- Verify the total number of outstanding shares (5,218,693,637) to confirm the percentage calculations provided.
- Confirm whether the "Below 5%" status for the Group and LGIM entities represents a decrease from a previous higher threshold or a maintenance of a sub-threshold position.
- Review the chain of controlled undertakings to understand the specific entities (e.g., PMC, LGAS, LGPL) holding the shares.
- Check subsequent filings to see if this transaction triggered any further disclosure obligations or changes in voting rights.